FFCP PHASE2:Hg19::chr4:57301896..57301945,+
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p3@PAICS |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_3_at_PAICS_5end |
Coexpression cluster: | C896_retinoblastoma_iPS_acute_lymphoma_chronic_Burkitt_testicular |
Association with transcript: | 0bp_to_ENST00000264221, ENST00000505164, ENST00000514888, NM_006452, uc003hbs.1, uc011cac.1_5end |
EntrezGene: | PAICS |
HGNC: | 8587 |
UniProt: | P22234E9PBS1D6RF62 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p3@PAICS |
---|
0
5
10
15
20
25
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
disease of cellular proliferation | 7.00e-24 | 239 |
cancer | 5.03e-23 | 235 |
hematologic cancer | 2.50e-16 | 51 |
immune system cancer | 2.50e-16 | 51 |
organ system cancer | 1.79e-13 | 137 |
leukemia | 6.72e-12 | 39 |
myeloid leukemia | 1.83e-08 | 31 |
cell type cancer | 1.10e-07 | 143 |
carcinoma | 2.99e-07 | 106 |
Showing 1 to 9 of 9 entries